Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMCIL LIMITED Net Asset Value 2025

Mar 3, 2025

64375_rns_2025-03-03_8c21cc05-977d-413b-8dba-06280bc39150.pdf

Net Asset Value

Open in viewer

Opens in your device viewer

4 March 2025

==> picture [596 x 78] intentionally omitted <==

Monthly net tangible asset (NTA) backing per share and top 20 investments as at 28 February 2025

Before Tax
After Tax
28 February2025 Ex Div $1.26
$1.13
31 January2025 Cum Div $1.37
$1.21
  • The before and after tax numbers relate to the provision for deferred tax on the unrealised gains in the Company’s investment portfolio. The Company is a long-term investor and does not intend disposing of its total long term investment portfolio. Under current Accounting Standards, the Company is required to provide for tax on any gains that may arise on such a theoretical disposal, after the utilisation of any brought forward losses.

The February 2025 figures are after the payment of the interim dividend of 1.0 cent per share while the January figures are before the provision for the dividend.

Key facts

Investment objectives: AMCIL is a medium to long-term investor in the Australian equity market. Its investment approach is to construct a focused portfolio in which large and small companies can have an equally important impact on investment returns.

Benchmark: S&P/ASX 200 Accumulation Index.

Size of portfolio: $403.9 million at 28 February 2025.

Low Management cost: 0.56 per cent, no additional fees. Investment style: Active, fundamental, bottom-up.

Suggested investment period: Five years to 10 years or longer.

Key benefits

Diversified portfolio primarily of ASX-listed Australian equities.

Tax-effective income via fully franked dividends. Consistent after tax paid investment returns achieved over the long term.

Professional management and an experienced Board, investment and management team.

Low-cost investing.

Ease of investing , transparent ASX pricing. Shareholder meetings on a regular basis.

Net asset backing: Estimated NTA released weekly and a monthly NTA with top 20 investments.

Listed on ASX: code AMH.

Portfolio performance percentage per annum-periods ending 28 February 2025*

==> picture [241 x 98] intentionally omitted <==

----- Start of picture text -----

1 year return 3 year return 5 year return 10 year return
Net asset per share growth [S&P/ASX 200 Accumulation ]
plus dividends, including franking Index, including franking
11.2% 10.7% 9.9% 10.3% 9.0% 9.0%
8.3%
5.4%
----- End of picture text -----

  • Assumes an investor can take full advantage of the franking credits. AMCIL’s portfolio return is also calculated after management fees, income tax and capital gains tax on realised sales of investments. It should be noted that Index returns for the market do not include management expenses or tax.

Share price premium/discount to NTA

==> picture [17 x 199] intentionally omitted <==

----- Start of picture text -----

15%
10%
5%
0%
-5%
-10%
-15%
-20%
----- End of picture text -----

==> picture [210 x 125] intentionally omitted <==

Past performance is not indicative of future performance.

Release authorised by Matthew Rowe, Company Secretary AMCIL Limited (AMCIL) – ABN 57 073 990 735

Share Registrar

Level 21, 101 Collins Street, Melbourne Victoria 3000 (03) 9650 9911 | [email protected] | amcil.com.au

MUFG Corporate Markets (AU) Limited au.investorcentre.mpms.mufg.com

1300 847 879 (in Australia) [email protected]

Page 1 of 2

==> picture [595 x 100] intentionally omitted <==

Portfolio facts

Investment by sector at 28 February 2025

Top 20 investments valued at closing prices at 28 February 2025

at 28 February 2025
Total Value % of the
$ Million Portfolio
1 CSL 31.6 8.1%
2 Macquarie Group 23.3 6.0%
3 Wesfarmers* 17.8 4.6%
4 BHP 17.6 4.5%
5 Goodman Group 17.1 4.4%
6 Transurban Group* 16.1 4.1%
7 Mainfreight 15.7 4.0%
8 CAR Group 15.1 3.9%
9
10
Macquarie Technology Group
ARB Corporation
13.7
13.2
3.5%
3.4%
Healthcare 15.7%
11 ResMed 12.5 3.2% Industrials14.0%
12 Netwealth Group 10.7 2.8% Information Technology 13.3%
13 James Hardie Industries 10.7 2.7% Other Financials 12.9%
14
15
EQT Holdings
ALS
9.1
8.9
2.3%
2.3%
Consumer Discretionary10.7%
16 WiseTech Global 8.9 2.3% Materials9.1%
17 Amcor 8.4 2.2% Communication Services8.9%
18 REA Group 8.4 2.2%
Real Estate5.9%
19
20
Gentrack Group
Fisher & Paykel Healthcare Corporation
7.2
7.0
1.9%
1.8%
Cash3.6%
Total 273.2 Banks 2.8%
As percentage of total portfolio value (excludes cash) 70.2% Consumer Staples 1.7%
Energy1.4%
  • Indicates that options were outstanding against part of the holding.

Important Information

This information has been prepared by AMCIL Limited (AMCIL) (ABN 57 073 990 735) and is provided by Australian Investment Company Services Limited, holder of Australian Financial Services Licence 303209 (Provider). To the extent that this information includes any financial product advice, the advice is of a general nature only and does not take into account any individual’s objectives, financial situation or particular needs. Before making an investment decision an individual should assess whether it meets their own needs and consult an appropriately licensed financial adviser. The information contained in these materials have been prepared in good faith. However, no warranty (express or implied) is made as to the accuracy, completeness or reliability of any statements, estimates or opinions or other information contained in these materials (any of which may change without notice) and to the maximum extent permitted by law, the Disclosers disclaim all liability and responsibility (including, without limitation, any liability arising from fault or negligence on the part of any or all of the Disclosers) for any direct or indirect loss or damage which may be suffered by any recipient through relying on anything contained in or omitted from these materials. A copy of the relevant Financial Services Guide can be found on AMCIL’s website: www.amcil.com.au

Page 2 of 2